Shagun Singh
Stock Analyst at RBC Capital
(2.51)
# 2,411
Out of 5,005 analysts
228
Total ratings
50.26%
Success rate
-0.86%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterates: Outperform | $125 | $96.83 | +29.09% | 17 | Sep 29, 2025 | |
| BDX Becton, Dickinson and Company | Initiates: Sector Perform | $211 | $192.30 | +9.72% | 1 | Sep 25, 2025 | |
| OM Outset Medical | Reiterates: Sector Perform | $22 | $14.95 | +47.16% | 13 | Aug 19, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Outperform | $615 | $451.60 | +36.18% | 16 | Aug 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $112 → $115 | $99.74 | +15.30% | 16 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Outperform | $330 → $350 | $307.54 | +13.81% | 2 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Outperform | $45 → $25 | $14.92 | +67.56% | 3 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $215 → $180 | $76.79 | +134.41% | 6 | Aug 5, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $130 → $135 | $128.92 | +4.72% | 22 | Aug 1, 2025 | |
| PEN Penumbra | Maintains: Outperform | $330 → $325 | $254.11 | +27.90% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $89 | $77.24 | +15.23% | 22 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $188.25 | -1.73% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.48 | +102.70% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $147 | $133.89 | +9.79% | 16 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $98.18 | +2.87% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $367.68 | +18.31% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $60.42 | +52.27% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $66.47 | +73.01% | 4 | Oct 25, 2024 |
Boston Scientific
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $96.83
Upside: +29.09%
Becton, Dickinson and Company
Sep 25, 2025
Initiates: Sector Perform
Price Target: $211
Current: $192.30
Upside: +9.72%
Outset Medical
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $14.95
Upside: +47.16%
Intuitive Surgical
Aug 19, 2025
Reiterates: Outperform
Price Target: $615
Current: $451.60
Upside: +36.18%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $112 → $115
Current: $99.74
Upside: +15.30%
Insulet
Aug 8, 2025
Maintains: Outperform
Price Target: $330 → $350
Current: $307.54
Upside: +13.81%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $14.92
Upside: +67.56%
Inspire Medical Systems
Aug 5, 2025
Maintains: Outperform
Price Target: $215 → $180
Current: $76.79
Upside: +134.41%
Teleflex
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $128.92
Upside: +4.72%
Penumbra
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $254.11
Upside: +27.90%
Jul 25, 2025
Maintains: Outperform
Price Target: $85 → $89
Current: $77.24
Upside: +15.23%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $188.25
Upside: -1.73%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.48
Upside: +102.70%
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $133.89
Upside: +9.79%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $98.18
Upside: +2.87%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $367.68
Upside: +18.31%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $60.42
Upside: +52.27%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $66.47
Upside: +73.01%